Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL). | Vaccine | 2021 | 33461835 | PubTator, text mining | PubMed |
| Evolution of antibody immunity to SARS-CoV-2. | Nature | 2021 | 33461210 | PubTator, text mining | PubMed |
| Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia. | J Hematol Oncol | 2021 | 33451349 | PubTator, text mining | PubMed |
| Immunotherapeutic Strategies for Neuroblastoma: Present, Past and Future. | Vaccines (Basel) | 2021 | 33450862 | PubTator, text mining | PubMed |
| Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada. | Curr Oncol | 2021 | 33435341 | PubTator, text mining | PubMed |
| Chronic Lymphocytic Leukemia: Prognostic Factors at Presentation in a Resource-Limited Center. | JCO Glob Oncol | 2021 | 33434067 | PubTator, text mining | PubMed |
| Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks. | Sci Rep | 2021 | 33431934 | PubTator, text mining | PubMed |
| Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia. | Exp Hematol | 2021 | 33421548 | PubTator, text mining | PubMed |
| Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative. | Ann Hematol | 2021 | 33409623 | PubTator, text mining | PubMed |
| EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia. | Hemasphere | 2021 | 33403356 | PubTator, text mining | PubMed |
| Neutralizing antibodies targeting SARS-CoV-2 spike protein. | Stem Cell Res | 2021 | 33341604 | PubTator, text mining | PubMed |
| A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia. | Int J Lab Hematol | 2021 | 33325634 | PubTator, text mining | PubMed |
| The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition. | J Mol Biol | 2021 | 33310017 | PubTator, text mining | PubMed |
| Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy. | Blood | 2021 | 33259589 | PubTator, text mining | PubMed |
| Comparison Between Venetoclax-based and Bruton Tyrosine Kinase Inhibitor-based Therapy as Upfront Treatment of Chronic Lymphocytic Leukemia (CLL): A Systematic Review and Network Meta-analysis. | Clin Lymphoma Myeloma Leuk | 2021 | 33199185 | PubTator, text mining | PubMed |
| miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors. | Blood | 2021 | 33171493 | PubTator, text mining | PubMed |
| Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact. | Haematologica | 2021 | 33147939 | PubTator, text mining | PubMed |
| Inhibitors targeting Bruton's tyrosine kinase in cancers: drug development advances. | Leukemia | 2021 | 33122850 | PubTator, text mining | PubMed |
| Association of an IGHV3-66 gene variant with Kawasaki disease. | J Hum Genet | 2021 | 33106546 | PubTator, text mining | PubMed |
| Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism. | Leukemia | 2021 | 33097837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=51